Dr. Mike Reed Joins Rosa & Co. Executive Management Team
Summary
Mike’s clinical pharmacology and drug development expertise combined with his significant physiologic modeling background will further enhance the relevance of our offerings to our bio-pharmaceutical clients worldwide," said Dr. Ron Beaver, PhD, Rosa’s Cofounder, Chairman, and CEO.Having worked at the bench and personally faced the critical challenges of time, money, and complexity, I feel that Rosa’s approach offers a unique strategic advantage.” About Rosa Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes.Rosa’s staff have close to two decades of unparalleled professional experience in using drug-disease modeling and simulation (M&S) to accelerate drug development; they have covered hundreds of applications with dozens of clients.Mike’s clinical pharmacology and drug development expertise combined with his significant physiologic modeling background will further enhance the relevance of our offerings to our bio-pharmaceutical clients worldwide," said Dr. Ron Beaver, PhD, Rosa’s Cofounder, Chairman, and CEO.“I’m excited to be joining the team at Rosa,” Mike added.Rosa’s staff have close to two decades of unparalleled professional experience in using drug-disease modeling and simulation (M&S) to accelerate drug development; they have covered hundreds of applications with dozens of clients.